Research paperIn vivo biodistribution of antihyperglycemic biopolymer-based nanoparticles for the treatment of type 1 and type 2 diabetes
Keywords: Insulin; Oral delivery; Biodistribution; Type 1 diabetes; Type 2 diabetes; 99mTc-BSA; technetium-99m-albumin; T1D; type 1 diabetes; T2D; type 2 diabetes; GI; gastrointestinal; NP; nanoparticles; PA; pharmacological availability; BSA; bovine serum albmin;